MKS Instruments Operating Cash Flow decreased by 62.7% to $53.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 62.4%, from $141.00M to $53.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a 0.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $165.00M | $153.00M | $195.00M | $41.00M | $105.00M | $199.00M | $184.00M | $37.00M | -$59.00M | $160.00M | $181.00M | $67.00M | $122.00M | $163.00M | $176.00M | $141.00M | $165.00M | $197.00M | $142.00M | $53.00M |
| QoQ Change | — | -7.3% | +27.5% | -79.0% | +156.1% | +89.5% | -7.5% | -79.9% | -259.5% | +371.2% | +13.1% | -63.0% | +82.1% | +33.6% | +8.0% | -19.9% | +17.0% | +19.4% | -27.9% | -62.7% |
| YoY Change | — | — | — | — | -36.4% | +30.1% | -5.6% | -9.8% | -156.2% | -19.6% | -1.6% | +81.1% | +306.8% | +1.9% | -2.8% | +110.4% | +35.2% | +20.9% | -19.3% | -62.4% |